IL HR0103

Urges the Department of Human Services and the Governor's Opioid Overdose Prevention and Recovery Steering Committee to consider funding FDA-authorized prescription digital therapeutics (PDTs) for substance use and opioid use disorders.

Identifies PDTs utilizing cognitive behavioral therapy and contingency management as FDA-approved tools with clinical evidence showing significantly greater odds of abstinence when combined with standard treatment.

Notes that PDTs can improve healthcare access for underserved populations by transcending geographic, socioeconomic, and institutional barriers to traditional treatment.

References the White House's 2022 National Drug Control Strategy document as supporting the use of prescription digital therapeutics to expand treatment services.

Directs delivery of the resolution to the Secretary of the Illinois Department of Human Services.